Trinity Integrated Medicine

Trinity Integrated Medicine operates a dedicated Spravato clinic in Mesa, Arizona, offering esketamine treatment for adults with treatment-resistant depression. Spravato is the first FDA-approved nasal spray for depression that has not responded to at least two standard antidepressants, and it is administered under provider supervision in the clinic.

Spravato works differently than conventional antidepressants, reaching the brain within hours rather than weeks. This fast onset can provide critical relief for patients experiencing acute suicidal thoughts. Providers oversee each treatment session and adjust care based on the patient's response.

Treatment at the Mesa clinic begins with a consultation and assessment of the patient's depression history, followed by in-office sessions and ongoing monitoring. Spravato is offered alongside counseling and medication management for lasting results, and the practice also provides TMS therapy.